Marker Therapeutics
(NASDAQ:MRKR)
Marker Therapeutics, Inc. - Common Stock is expected to split Friday, August 19, 2022 with a ratio of 1:4
Marker Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$0.3936
-0.0549[-12.24%]
At close: Aug 12
$0.4051
0.0115[2.92%]
After Hours: 6:18PM EDT
Day High/Low0.38 - 0.46
52 Week High/Low0.25 - 1.03
Open / Close0.46 / 0.39
Float / Outstanding58.8M / 83.6M
Vol / Avg.979.4K / 1.7M
Mkt Cap32.9M
P/E-
50d Avg. Price0.34
Div / Yield-
Payout Ratio-
EPS-0.12
Total Float58.8M

Marker Therapeutics (NASDAQ:MRKR), Quotes and News Summary

Marker Therapeutics (NASDAQ: MRKR)

Day High/Low0.38 - 0.46
52 Week High/Low0.25 - 1.03
Open / Close0.46 / 0.39
Float / Outstanding58.8M / 83.6M
Vol / Avg.979.4K / 1.7M
Mkt Cap32.9M
P/E-
50d Avg. Price0.34
Div / Yield-
Payout Ratio-
EPS-0.12
Total Float58.8M
Sector: Health Care.Industry: Biotechnology
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Marker Therapeutics Questions & Answers

Q
How do I buy Marker Therapeutics (MRKR) stock?
A

You can purchase shares of Marker Therapeutics (NASDAQ: MRKR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Marker Therapeutics's (MRKR) competitors?
Q
What is the target price for Marker Therapeutics (MRKR) stock?
A

The latest price target for Marker Therapeutics (NASDAQ: MRKR) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting MRKR to rise to within 12 months (a possible 916.26% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Marker Therapeutics (MRKR)?
A

The stock price for Marker Therapeutics (NASDAQ: MRKR) is $0.3936 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Marker Therapeutics (MRKR) pay a dividend?
A

The next Marker Therapeutics (MRKR) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?
A

Marker Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Marker Therapeutics (MRKR) going to split?
A

There is no upcoming split for Marker Therapeutics.

Q
What sector and industry does Marker Therapeutics (MRKR) operate in?
A

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.